Claudin 1: in Cancer and Organ Fibrosis

Time: 2:15 pm
day: Conference Day 2

Details:

  • Examining the role of Claudin 1 in cancer and organ fibrosis
  • Discussing the pre-clinical development and the therapeutic potential of monoclonal antibodies and ADCs targeting Claudin 1
  • Addressing the phase I development for Claudin 1-targeted therapies

Speakers: